Document is current
Any future updates will be listed below
-
Authors
Fernando, Rangika L. https://orcid.org/0000-0002-2840-204X
Karnon, Jonathan https://orcid.org/0000-0003-3220-2099
Crotty, Maria https://orcid.org/0000-0002-2996-5135
Inacio, Maria C. https://orcid.org/0000-0001-8261-2665
Baillie, Madeleine
Batta, Ishita
Bourke, Alice
Forward, John
Furst, Chloe
Jorissen, Robert https://orcid.org/0000-0001-9634-2803
Neill, Georgina
Szabo, Georgina https://orcid.org/0009-0003-7866-2434
Whitehead, Craig
Harvey, Gillian https://orcid.org/0000-0003-0937-7819
-
Funding
Funding for this research was provided by:
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
Australian Government Medical Research Future Fund (2018250)
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 19 June 2025
First Online: 28 July 2025
Declarations
:
: The OPTIMAL trial received ethics approval for all participating sites from the Southern Adelaide Clinical Human Research Ethics Committee (Approval 2023/HRE00111) and is prospectively registered with the Australia New Zealand Clinical Trial Registry ACTRN12624001008516, registered 20th August 2024. The relevant governance approvals were obtained for each participating LHN. Approval for any identified variations to the approved protocol will be sought from the approving ethics committee and governance officers and communicated as required.A waiver of the requirement for consent was granted by the ethics committee for routinely collected patient data. Written informed consent for participation will be obtained from each participant prior to the interviews. Informed consent will be obtained from all survey participants prior to completing the online survey via the Qualtrics platform.
: Not applicable.
: The authors declare no competing interests.
